Body temperature and response to thrombolytic therapy in acute ischaemic stroke

被引:30
作者
Millan, M. [1 ,2 ]
Grau, L. [1 ,2 ]
Castellanos, M. [3 ]
Rodriguez-yanez, M. [4 ]
Arenillas, J. F. [1 ,2 ]
Nombela, F. [5 ]
Perez de la Ossa, N. [1 ,2 ]
Lopez-Manzanares, L. [5 ]
Serena, J. [3 ]
Castillo, J. [4 ]
Davalos, A. [1 ,2 ]
机构
[1] Hosp Univ Germans Trias & Pujol, Dept Neurosci, Badalona 08916, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[3] Hosp Univ Doctor Josep Trueta, Dept Neurol, Girona, Spain
[4] Univ Santiago de Compostela, Hosp Clin Univ, Dept Neurol, Santiago De Compostela, Spain
[5] Hosp Princesa, Dept Neurol, Madrid, Spain
关键词
hyperthermia; ischaemic stroke; temperature; thrombolysis;
D O I
10.1111/j.1468-1331.2008.02321.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To determine the relationship between body temperature (BT), arterial recanalization, functional outcome, and hemorrhagic transformation (HT) of cerebral infarction in patients treated with i.v. tissue plasminogen activator (tPA). We studied 254 patients treated with tPA within 3 h from stroke onset. National Institute of Health Stroke Scale score, BT, and transcranial Doppler ultrasound (n = 99) on admission and at 24 h were recorded. Hypodensity volume and HT were evaluated on CT at 24-36 h. Poor outcome (Rankin Scale > 2) was evaluated at 3 months. Arterial recanalization at 24 h was found in 70.7% of patients, HT in 24.8% (symptomatic in 4.7%) and poor outcome in 44.1%. Baseline BT was not associated with greater stroke severity at admission or at 24 h, HT or poor outcome. However, BT at 24 h correlated to stroke severity (P < 0.001) and hypodensity volume (P < 0.001) at 24 h, and was higher in patients who did not recanalize (P = 0.001), had symptomatic HT (P = 0.063) and poor outcome (P < 0.001). The adjusted odds ratio of poor outcome for patients with BT at 24 h >= 37 degrees C was 2.56 (1.19-5.50, P = 0.016). Body temperature >= 37 degrees C at 24 h, but not at baseline, is associated with a lack of recanalization, greater hypodensity volume and worse outcome in stroke patients treated with tPA.
引用
收藏
页码:1384 / 1389
页数:6
相关论文
共 29 条
[1]   FEVER IN ACUTE STROKE WORSENS PROGNOSIS - A PROSPECTIVE-STUDY [J].
AZZIMONDI, G ;
BASSEIN, L ;
NONINO, F ;
FIORANI, L ;
VIGNATELLI, L ;
RE, G ;
DALESSANDRO, R .
STROKE, 1995, 26 (11) :2040-2043
[2]   Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia [J].
Baena, RC ;
Busto, R ;
Dietrich, WD ;
Globus, MYT ;
Ginsberg, MD .
NEUROLOGY, 1997, 48 (03) :768-773
[3]   Stroke severity determines body temperature in acute stroke [J].
Boysen, G ;
Christensen, H .
STROKE, 2001, 32 (02) :413-417
[4]   Aggravation of acute ischemic stroke by hyperthermia is related to an excitotoxic mechanism [J].
Castillo, J ;
Dávalos, A ;
Noya, M .
CEREBROVASCULAR DISEASES, 1999, 9 (01) :22-27
[5]   MORTALITY AND MORBIDITY OF ACUTE CEREBRAL INFARCTION RELATED TO TEMPERATURE AND BASAL ANALYTIC PARAMETERS [J].
CASTILLO, J ;
MARTINEZ, F ;
LEIRA, R ;
PRIETO, JM ;
LEMA, M ;
NOYA, M .
CEREBROVASCULAR DISEASES, 1994, 4 (02) :66-71
[6]   Timing for fever-related brain damage in acute ischemic stroke [J].
Castillo, J ;
Dávalos, A ;
Marrugat, J ;
Noya, M .
STROKE, 1998, 29 (12) :2455-2460
[7]   Infection after acute ischemic stroke - A manifestation of brain-induced immunodepression [J].
Chamorro, Angel ;
Urra, Xabier ;
Planas, Anna M. .
STROKE, 2007, 38 (03) :1097-1103
[8]   EFFECT OF MILD HYPERTHERMIA ON THE ISCHEMIC INFARCT VOLUME AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION IN THE RAT [J].
CHEN, H ;
CHOPP, M ;
WELCH, KMA .
NEUROLOGY, 1991, 41 (07) :1133-1135
[9]   Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke [J].
Christou, I ;
Alexandrov, AV ;
Burgin, WS ;
Wojner, AW ;
Felberg, RA ;
Malkoff, M ;
Grotta, JC .
STROKE, 2000, 31 (08) :1812-1816
[10]   Thrombolysis in Brain Ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator [J].
Demchuk, AM ;
Burgin, WS ;
Christou, I ;
Felberg, RA ;
Barber, PA ;
Hill, MD ;
Alexandrov, AV .
STROKE, 2001, 32 (01) :89-93